FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4285011352> ?p ?o ?g. }

• W4285011352 abstract "Abstract Background A balanced anaesthetic protocol is a common concept in modern veterinary anaesthesia and aims to maintain good intraoperative cardiopulmonary function. In horses, alpha-2-agonists produce sedation and analgesia and have been shown to reduce inhalational anaesthetic requirements when administered intravenously. Furthermore, these drugs can improve recovery quality. Preliminary investigations of subcutaneous dexmedetomidine administration in humans demonstrated a reduced haemodynamic impact if compared with the intravenous route suggesting that dexmedetomidine is adequately absorbed with both administration routes. The aim of the study was to compare two different dexmedetomidine (DEX) administration routes: intravenous constant rate infusion (CRI) versus repeated subcutaneous (SC) injections on cardiopulmonary function and recovery in anaesthetized horses. Results No significant differences between groups in heart rate and systolic arterial pressure were detected. A significantly higher mean and diastolic arterial pressure were detected in the SC group at T25 ( p = 0.04; p = 0.02), T75 ( p = 0.02; p = 0.009), and T85 ( p = 0.001; p = 0.005). In SC group there was a significantly lower dobutamine infusion rate ( p = 0.03) and a significantly higher urinary output ( p = 0.02). Moreover, recovery quality was higher ( p = 0.01). Conclusions Cardiopulmonary effects in both groups were comparable and within clinical ranges with less dobutamine requirement in the subcutaneous group. Recovery was of better quality with fewer attempts in horses receiving subcutaneous dexmedetomidine. The present study suggests that intravenous constant rate infusion and subcutaneous repeated administration of dexmedetomidine at indicated dosage can be useful in balanced anaesthesia without any systemic or local adverse effects; moreover, in healthy horses undergoing general anaesthesia, repeated subcutaneous dexmedetomidine administration may be a suitable alternative if constant rate infusion is not feasible." @default.
• W4285011352 created "2022-07-12" @default.
• W4285011352 creator A5002242375 @default.
• W4285011352 creator A5020148111 @default.
• W4285011352 creator A5025747682 @default.
• W4285011352 creator A5046300924 @default.
• W4285011352 creator A5047292462 @default.
• W4285011352 creator A5069919818 @default.
• W4285011352 creator A5076820454 @default.
• W4285011352 creator A5085288775 @default.
• W4285011352 creator A5091420706 @default.
• W4285011352 date "2022-07-11" @default.
• W4285011352 modified "2023-09-26" @default.
• W4285011352 title "Use of dexmedetomidine repeated subcutaneous administration for balanced anaesthesia in horses" @default.
• W4285011352 cites W1466590307 @default.
• W4285011352 cites W1560066735 @default.
• W4285011352 cites W1573298363 @default.
• W4285011352 cites W1949723969 @default.
• W4285011352 cites W1970837652 @default.
• W4285011352 cites W2020096696 @default.
• W4285011352 cites W2021697998 @default.
• W4285011352 cites W2026777668 @default.
• W4285011352 cites W2030399546 @default.
• W4285011352 cites W2046125243 @default.
• W4285011352 cites W2062025618 @default.
• W4285011352 cites W2070269233 @default.
• W4285011352 cites W2072000642 @default.
• W4285011352 cites W2073561450 @default.
• W4285011352 cites W2076982340 @default.
• W4285011352 cites W2083075735 @default.
• W4285011352 cites W2083959401 @default.
• W4285011352 cites W2104104810 @default.
• W4285011352 cites W2111005595 @default.
• W4285011352 cites W2111354448 @default.
• W4285011352 cites W2129427669 @default.
• W4285011352 cites W2164863205 @default.
• W4285011352 cites W2170378855 @default.
• W4285011352 cites W2282421132 @default.
• W4285011352 cites W2294249773 @default.
• W4285011352 cites W2400211425 @default.
• W4285011352 cites W2409060235 @default.
• W4285011352 cites W2409256518 @default.
• W4285011352 cites W2413868560 @default.
• W4285011352 cites W2418226043 @default.
• W4285011352 cites W2469481996 @default.
• W4285011352 cites W2518688659 @default.
• W4285011352 cites W2609829012 @default.
• W4285011352 cites W2750524685 @default.
• W4285011352 cites W2801978448 @default.
• W4285011352 cites W2883052264 @default.
• W4285011352 cites W2950029022 @default.
• W4285011352 cites W2952182506 @default.
• W4285011352 cites W3096548538 @default.
• W4285011352 cites W4313371117 @default.
• W4285011352 doi "https://doi.org/10.1186/s12917-022-03350-0" @default.
• W4285011352 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/35818051" @default.
• W4285011352 hasPublicationYear "2022" @default.
• W4285011352 type Work @default.
• W4285011352 citedByCount "0" @default.
• W4285011352 crossrefType "journal-article" @default.
• W4285011352 hasAuthorship W4285011352A5002242375 @default.
• W4285011352 hasAuthorship W4285011352A5020148111 @default.
• W4285011352 hasAuthorship W4285011352A5025747682 @default.
• W4285011352 hasAuthorship W4285011352A5046300924 @default.
• W4285011352 hasAuthorship W4285011352A5047292462 @default.
• W4285011352 hasAuthorship W4285011352A5069919818 @default.
• W4285011352 hasAuthorship W4285011352A5076820454 @default.
• W4285011352 hasAuthorship W4285011352A5085288775 @default.
• W4285011352 hasAuthorship W4285011352A5091420706 @default.
• W4285011352 hasBestOaLocation W42850113521 @default.
• W4285011352 hasConcept C126322002 @default.
• W4285011352 hasConcept C178853913 @default.
• W4285011352 hasConcept C2776814716 @default.
• W4285011352 hasConcept C2777953023 @default.
• W4285011352 hasConcept C2779520467 @default.
• W4285011352 hasConcept C2781185063 @default.
• W4285011352 hasConcept C2781302539 @default.
• W4285011352 hasConcept C42219234 @default.
• W4285011352 hasConcept C71924100 @default.
• W4285011352 hasConcept C84393581 @default.
• W4285011352 hasConceptScore W4285011352C126322002 @default.
• W4285011352 hasConceptScore W4285011352C178853913 @default.
• W4285011352 hasConceptScore W4285011352C2776814716 @default.
• W4285011352 hasConceptScore W4285011352C2777953023 @default.
• W4285011352 hasConceptScore W4285011352C2779520467 @default.
• W4285011352 hasConceptScore W4285011352C2781185063 @default.
• W4285011352 hasConceptScore W4285011352C2781302539 @default.
• W4285011352 hasConceptScore W4285011352C42219234 @default.
• W4285011352 hasConceptScore W4285011352C71924100 @default.
• W4285011352 hasConceptScore W4285011352C84393581 @default.
• W4285011352 hasIssue "1" @default.
• W4285011352 hasLocation W42850113521 @default.
• W4285011352 hasLocation W42850113522 @default.
• W4285011352 hasLocation W42850113523 @default.
• W4285011352 hasLocation W42850113524 @default.
• W4285011352 hasOpenAccess W4285011352 @default.
• W4285011352 hasPrimaryLocation W42850113521 @default.
• W4285011352 hasRelatedWork W2033116206 @default.
• W4285011352 hasRelatedWork W2359780091 @default.
• W4285011352 hasRelatedWork W2604185023 @default.

• next